|
SSR4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.18549680761771E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.724499999467E-07 |
| Normal-vs-Stage2 |
8.644200E-03 |
| Normal-vs-Stage3 |
6.447800E-04 |
| Normal-vs-Stage4 |
7.856700E-03 |
| Stage1-vs-Stage2 |
3.303800E-01 |
| Stage1-vs-Stage3 |
6.983900E-02 |
| Stage1-vs-Stage4 |
4.215000E-01 |
| Stage2-vs-Stage3 |
5.384600E-01 |
| Stage2-vs-Stage4 |
8.789000E-01 |
| Stage3-vs-Stage4 |
3.849000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.23350002329192E-09 |
| Normal-vs-AfricanAmerican |
2.32259999999318E-06 |
| Normal-vs-Asian |
5.015200E-03 |
| Caucasian-vs-AfricanAmerican |
5.635600E-01 |
| Caucasian-vs-Asian |
7.290000E-02 |
| AfricanAmerican-vs-Asian |
1.078630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.68369999556484E-08 |
| Normal-vs-Female |
8.26260004860302E-09 |
| Male-vs-Female |
1.096310E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.28539999999056E-05 |
| Normal-vs-Extreme_Weight |
3.09440000290095E-08 |
| Normal-vs-Obese |
1.75503999999549E-05 |
| Normal-vs-Extreme_Obese |
2.967200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.778600E-01 |
| Normal_Weight-vs-Obese |
5.818200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.000600E-01 |
| Extreme_Weight-vs-Obese |
7.163800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.963840E-01 |
| Obese-vs-Extreme_Obese |
3.081600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.980500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.30899999728484E-08 |
| Normal-vs-Age(61-80Yrs) |
1.22260000012808E-07 |
| Normal-vs-Age(81-100Yrs) |
1.162950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.742840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.026200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.127970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.395800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.623600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.774400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.51980000029361E-07 |
| Normal-VS-Type2 PRCC |
1.360520E-04 |
| Normal-VS-KIRP CIMP |
1.783850E-04 |
| Normal-VS-Unclassified PRCC |
3.79169999999984E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.908600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.843700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.391800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.017800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.879200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.752400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60220000000599E-06 |
| Normal-vs-N1 |
4.240900E-03 |
| Normal-vs-N2 |
3.498200E-02 |
| N0-vs-N1 |
4.722000E-01 |
| N0-vs-N2 |
8.025900E-02 |
| N1-vs-N2 |
4.296600E-01 |
|
|
